Materialise
Nasdaq MTLS · Levuen, Belgium
Works in Musculoskeletal
Materialise is a clinical trial sponsor based in Levuen, Belgium, listed as Nasdaq MTLS. It has 3 active clinical trials with 254 planned participants, in Musculoskeletal.
Trial track record · since 2021
Financials · Nasdaq MTLS
Pipeline · 3 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Materialise
Materialise is lead sponsor of 3 active clinical trials on ClinicalTrials.gov, with 254 planned participants, in Musculoskeletal. Since 2021 it has completed 0 trials and stopped 0 early.
Materialise is based in Levuen, Belgium and is listed as Nasdaq MTLS. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Materialise; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-13.
Approve Suite is not affiliated with Materialise.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.